Acumen Pharmaceuticals, Inc. Capital Expenditures Incurred but Not yet Paid
Acumen Pharmaceuticals, Inc. (ABOS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-08-12
- Acumen Pharmaceuticals, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $0.00.
- Acumen Pharmaceuticals, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Acumen Pharmaceuticals, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$69.00K.
- Acumen Pharmaceuticals, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $78.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |
| 2024-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $9.00K 10-Q · filed 2025-08-12 |
| 2024-03-31 | $78.00K 10-Q · filed 2025-05-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | |
| 2022-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $42.00K 10-Q · filed 2023-08-08 |
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |